创新链/学科链/研发链/产业链

新药研发前沿动态 / 医药领域趋势进展

阎俪, 马雄. 自身免疫性肝病的治疗药物研究进展[J]. 药学进展, 2018, 42(5): 333-336.
引用本文: 阎俪, 马雄. 自身免疫性肝病的治疗药物研究进展[J]. 药学进展, 2018, 42(5): 333-336.
YAN Li, MA Xiong. Recent Progress in Therapeutic Drugs of Autoimmune Liver Diseases[J]. Progress in Pharmaceutical Sciences, 2018, 42(5): 333-336.
Citation: YAN Li, MA Xiong. Recent Progress in Therapeutic Drugs of Autoimmune Liver Diseases[J]. Progress in Pharmaceutical Sciences, 2018, 42(5): 333-336.

自身免疫性肝病的治疗药物研究进展

Recent Progress in Therapeutic Drugs of Autoimmune Liver Diseases

  • 摘要: 自身免疫性肝病是一组由自身免疫介导的肝脏炎症性疾病,主要包括自身免疫性肝炎、原发性胆汁性胆管炎及原发性硬化性胆管炎等。近年来,自身免疫性肝病逐渐成为肝病领域的研究热点,其治疗药物的研究也有了新的突破。综述自身免疫性肝病治疗药物的研究进展。

     

    Abstract: Autoimmune liver diseases are a group of autoimmune-induced inflammatory liver diseases, mainly including autoimmune hepatitis, primary biliary cholangitis and primary sclerosing cholangitis. Recently, autoimmune liver diseases have become the research focus in the field of liver disease, with new breakthroughs in the development of therapeutic drugs. This article reviewed the research progress in therapeutic drugs of autoimmune liver diseases.

     

/

返回文章
返回